Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic Dermatitis
- 1 October 2005
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 125 (4), 738-745
- https://doi.org/10.1111/j.0022-202x.2005.23776.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003Journal of Allergy and Clinical Immunology, 2004
- Atopic dermatitisThe Lancet, 2003
- Innate antimicrobial peptide protects the skin from invasive bacterial infectionNature, 2001
- Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A StreptococcusJournal of Investigative Dermatology, 2001
- IL-10: Evolving conceptsJournal of Allergy and Clinical Immunology, 1998
- IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.JCI Insight, 1998
- Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.JCI Insight, 1997
- Differential Cytokine Profiles in Peripheral Blood Lymphocyte Supernatants and Skin Biopsies from Patients with Different Forms of Atopic Dermatitis, Psoriasis and Normal IndividualsInternational Archives of Allergy and Immunology, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991